{Reference Type}: Journal Article
{Title}: Percutaneous radiofrequency ablation of ovarian cancer metastasis in the spleen: a therapeutic option to consider.
{Author}: Boccatonda A;Mauloni PA;Cevenini M;Masi L;Bakken SM;Serra C;
{Journal}: J Ultrasound
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 20
暂无{DOI}: 10.1007/s40477-024-00921-9
{Abstract}: Splenic metastasis are rare clinical entities developing in less than 1% of all metastatic cancers and usually in the setting of disseminated disease. To date, splenectomy is traditionally the first line therapy in patient with splenic metastasis, however non-surgical therapies have been reported. Here we described the case of a 57-year-old patient with splenic metastasis from ovarian cancer successfully treated by percutaneous radiofrequency ablation. Furthermore, we performed a literature systematic review of the cases of splenic metastases treated by thermal ablation.